Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1959 1
1960 1
2000 2
2012 2
2013 1
2014 2
2015 4
2016 4
2017 1
2018 8
2019 11
2020 11
2021 11
2022 18
2023 13
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation.
Arifuzzaman M, Won TH, Li TT, Yano H, Digumarthi S, Heras AF, Zhang W, Parkhurst CN, Kashyap S, Jin WB, Putzel GG, Tsou AM, Chu C, Wei Q, Grier A; JRI IBD Live Cell Bank Consortium; Worgall S, Guo CJ, Schroeder FC, Artis D. Arifuzzaman M, et al. Nature. 2022 Nov;611(7936):578-584. doi: 10.1038/s41586-022-05380-y. Epub 2022 Nov 2. Nature. 2022. PMID: 36323778 Free PMC article.
Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.
Tsou AM, Yano H, Parkhurst CN, Mahlakõiv T, Chu C, Zhang W, He Z, Jarick KJ, Zhong C, Putzel GG, Hatazaki M; JRI IBD Live Cell Bank Consortium; Lorenz IC, Andrew D, Balderes P, Klose CSN, Lira SA, Artis D. Tsou AM, et al. Nature. 2022 Nov;611(7937):787-793. doi: 10.1038/s41586-022-05297-6. Epub 2022 Nov 2. Nature. 2022. PMID: 36323781 Free PMC article.
ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut.
Lyu M, Suzuki H, Kang L, Gaspal F, Zhou W, Goc J, Zhou L, Zhou J, Zhang W; JRI Live Cell Bank; Shen Z, Fox JG, Sockolow RE, Laufer TM, Fan Y, Eberl G, Withers DR, Sonnenberg GF. Lyu M, et al. Nature. 2022 Oct;610(7933):744-751. doi: 10.1038/s41586-022-05141-x. Epub 2022 Sep 7. Nature. 2022. PMID: 36071169 Free PMC article.
ZBTB46 defines and regulates ILC3s that protect the intestine.
Zhou W, Zhou L, Zhou J; JRI Live Cell Bank; Chu C, Zhang C, Sockolow RE, Eberl G, Sonnenberg GF. Zhou W, et al. Nature. 2022 Sep;609(7925):159-165. doi: 10.1038/s41586-022-04934-4. Epub 2022 Jul 13. Nature. 2022. PMID: 35831503 Free PMC article.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Dulai PS, Singh S, Vande Casteele N, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV Jr, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C. Dulai PS, et al. Among authors: lukin d. Clin Gastroenterol Hepatol. 2020 Dec;18(13):2952-2961.e8. doi: 10.1016/j.cgh.2020.02.010. Epub 2020 Feb 13. Clin Gastroenterol Hepatol. 2020. PMID: 32062041 Free PMC article.
Vaccination in the Elderly and IBD.
Choi AJ, Atteberry P, Lukin DJ. Choi AJ, et al. Among authors: lukin dj. Curr Treat Options Gastroenterol. 2019 Dec;17(4):492-505. doi: 10.1007/s11938-019-00257-y. Curr Treat Options Gastroenterol. 2019. PMID: 31686385 Review.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV Jr, Dulai PS. Johnson AM, et al. Among authors: lukin d. Am J Gastroenterol. 2023 Feb 1;118(2):317-328. doi: 10.14309/ajg.0000000000002047. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191274
Inverse-designed diamond photonics.
Dory C, Vercruysse D, Yang KY, Sapra NV, Rugar AE, Sun S, Lukin DM, Piggott AY, Zhang JL, Radulaski M, Lagoudakis KG, Su L, Vučković J. Dory C, et al. Among authors: lukin dm. Nat Commun. 2019 Jul 25;10(1):3309. doi: 10.1038/s41467-019-11343-1. Nat Commun. 2019. PMID: 31346175 Free PMC article.
83 results